Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) EPS (Basic): 2018-2025

Historic EPS (Basic) for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to -$0.99.

  • Neurogene's EPS (Basic) rose 16.81% to -$0.99 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.11, marking a year-over-year decrease of 116.79%. This contributed to the annual value of -$4.28 for FY2024, which is 80.90% up from last year.
  • Latest data reveals that Neurogene reported EPS (Basic) of -$0.99 as of Q3 2025, which was up 5.71% from -$1.05 recorded in Q2 2025.
  • In the past 5 years, Neurogene's EPS (Basic) ranged from a high of $27.76 in Q4 2023 and a low of -$32.67 during Q3 2023.
  • For the 3-year period, Neurogene's EPS (Basic) averaged around -$6.11, with its median value being -$1.08 (2025).
  • Over the last 5 years, Neurogene's EPS (Basic) had its largest YoY gain of 96.46% in 2024, and its largest YoY loss of 103.57% in 2024.
  • Over the past 3 years, Neurogene's EPS (Basic) (Quarterly) stood at $27.76 in 2023, then tumbled by 103.57% to -$0.99 in 2024, then rose by 16.81% to -$0.99 in 2025.
  • Its last three reported values are -$0.99 in Q3 2025, -$1.05 for Q2 2025, and -$1.08 during Q1 2025.